ResearcherRoswell Park Comprehensive Cancer CenterNo recent work listed
Sandeep Kumar
Matched on ORCID iD 0000-0002-2376-6469; OpenAlex author ID A5084318911. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 2 papers
Papers 5
- Calcium channel blockers potentiate gemcitabine chemotherapy in pancreatic cancer. Co-author DOI 10.1073/pnas.2200143119↗
- Loss of SMAD4 Is Associated With Poor Tumor Immunogenicity and Reduced PD-L1 Expression in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2022.806963↗
- Mixed Lineage Kinase 3 phosphorylates prolyl-isomerase PIN1 and potentiates GLI1 signaling in pancreatic cancer development. Co-author DOI 10.1016/j.canlet.2021.04.015↗
- TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell-Mediated Regression of Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-18-0850↗
- Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2017.10.029↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Daniel R. Principe · 4 shared papers, 2019–2022 · strength 0.51
- Paper Loss of SMAD4 Is Associated With Poor Tumor Immunogenicity and Reduced PD-L1 Expression in Pancreatic Cancer. DOI 10.3389/fonc.2022.806963↗
- Paper Calcium channel blockers potentiate gemcitabine chemotherapy in pancreatic cancer. DOI 10.1073/pnas.2200143119↗
- Paper Mixed Lineage Kinase 3 phosphorylates prolyl-isomerase PIN1 and potentiates GLI1 signaling in pancreatic cancer develop… DOI 10.1016/j.canlet.2021.04.015↗
- Ajay Nmn Rana · 4 shared papers, 2019–2022 · strength 0.51
- Paper Loss of SMAD4 Is Associated With Poor Tumor Immunogenicity and Reduced PD-L1 Expression in Pancreatic Cancer. DOI 10.3389/fonc.2022.806963↗
- Paper Calcium channel blockers potentiate gemcitabine chemotherapy in pancreatic cancer. DOI 10.1073/pnas.2200143119↗
- Paper Mixed Lineage Kinase 3 phosphorylates prolyl-isomerase PIN1 and potentiates GLI1 signaling in pancreatic cancer develop… DOI 10.1016/j.canlet.2021.04.015↗
- Hidayatullah G. Munshi · 3 shared papers, 2019–2022 · strength 0.40
- Paper Loss of SMAD4 Is Associated With Poor Tumor Immunogenicity and Reduced PD-L1 Expression in Pancreatic Cancer. DOI 10.3389/fonc.2022.806963↗
- Paper Calcium channel blockers potentiate gemcitabine chemotherapy in pancreatic cancer. DOI 10.1073/pnas.2200143119↗
- Paper TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell-Mediated Regression of Pancreatic Cancer. DOI 10.1158/1535-7163.mct-18-0850↗
- Patrick W. Underwood · 2 shared papers, 2022 · strength 0.31
- Navin Viswakarma · 2 shared papers, 2019–2021 · strength 0.21
- Paper Mixed Lineage Kinase 3 phosphorylates prolyl-isomerase PIN1 and potentiates GLI1 signaling in pancreatic cancer develop… DOI 10.1016/j.canlet.2021.04.015↗
- Paper TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell-Mediated Regression of Pancreatic Cancer. DOI 10.1158/1535-7163.mct-18-0850↗
- Paul J. Grippo · 2 shared papers, 2019–2021 · strength 0.21
- Paper Mixed Lineage Kinase 3 phosphorylates prolyl-isomerase PIN1 and potentiates GLI1 signaling in pancreatic cancer develop… DOI 10.1016/j.canlet.2021.04.015↗
- Paper TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell-Mediated Regression of Pancreatic Cancer. DOI 10.1158/1535-7163.mct-18-0850↗
- Jose Gilberto Trevino · 1 shared paper, 2022 · strength 0.16
- Thao D. Pham · 1 shared paper, 2022 · strength 0.14
- Jose Trevino · 1 shared paper, 2022 · strength 0.14
- Pier Cristoforo Giulianotti · 1 shared paper, 2021 · strength 0.12
- Carolina Torres · 1 shared paper, 2019 · strength 0.09
- Dhyan Chandra · 1 shared paper, 2018 · strength 0.07
- Steven N. Hochwald · 1 shared paper, 2018 · strength 0.07
- Xinjiang Wang · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.